Latest period
895.90M
YoY change
-0.7%
5Y CAGR
-1.3%
Peak year (1993)
1.20B
Latest annual
898.00M
Shares Outstanding history chart for Eli Lilly (LLY) from 1985 to 2025
Latest: 898.00M
Shares Outstanding growth chart for Eli Lilly (LLY) from 1985 to 2025
Latest: -0.7%
Shares Outstanding history table for Eli Lilly (LLY) from 1985 to 2025
| 2025 | 898.00M | -0.7% | -6.06M | ||
| 2024 | 904.06M | +0.1% | +775,000 | ||
| 2023 | 903.28M | -4.9% | -46.90M | ||
| 2022 | 950.18M | -0.4% | -3.47M | ||
| 2021 | 953.65M | -0.3% | -2.94M | ||
| 2020 | 956.59M | -0.1% | -936,000 | ||
| 2019 | 957.53M | -7.4% | -76.14M | ||
| 2018 | 1.03B | -1.7% | -18.36M | ||
| 2017 | 1.05B | -4.4% | -48.85M | ||
| 2016 | 1.10B | -0.4% | -4.39M | ||
| 2015 | 1.11B | -0.5% | -5.36M | ||
| 2014 | 1.11B | -0.6% | -6.17M | ||
| 2013 | 1.12B | -2.6% | -29.70M | ||
| 2012 | 1.15B | +2.9% | +32.53M | ||
| 2011 | 1.11B | +0.7% | +8.15M | ||
| 2010 | 1.11B | +0.7% | +7.45M | ||
| 2009 | 1.10B | +0.4% | +3.87M | ||
| 2008 | 1.09B | +0.3% | +3.75M | ||
| 2007 | 1.09B | +0.4% | +3.93M | ||
| 2006 | 1.09B | -0.6% | -6.89M | ||
| 2005 | 1.09B | +0.3% | +3.28M | ||
| 2004 | 1.09B | +0.9% | +9.92M | ||
| 2003 | 1.08B | -0.2% | -2.65M | ||
| 2002 | 1.08B | -0.6% | -7.04M | ||
| 2001 | 1.09B | -0.5% | -5.79M | ||
| 2000 | 1.10B | -0.9% | -10.07M | ||
| 1999 | 1.11B | -1.3% | -14.32M | ||
| 1998 | 1.12B | -0.9% | -10.20M | ||
| 1997 | 1.13B | +1.2% | +13.47M | ||
| 1996 | 1.12B | -5.1% | -59.83M | ||
| 1995 | 1.18B | +0.8% | +8.98M | ||
| 1994 | 1.17B | -2.7% | -32.53M | ||
| 1993 | 1.20B | +3.3% | +38.70M | ||
| 1992 | 1.16B | -0.1% | -1.65M | ||
| 1991 | 1.16B | +1.1% | +13.14M | ||
| 1990 | 1.15B | -2.0% | -24.07M | ||
| 1989 | 1.17B | +3.4% | +38.55M | ||
| 1988 | 1.14B | -1.2% | -13.64M | ||
| 1987 | 1.15B | +5.0% | +54.95M | ||
| 1986 | 1.09B | -0.6% | -6.77M | ||
| 1985 | 1.10B | — | — |
- 2025898.00M-0.7%
- 2024904.06M+0.1%
- 2023903.28M-4.9%
- 2022950.18M-0.4%
- 2021953.65M-0.3%
- 2020956.59M-0.1%
- 2019957.53M-7.4%
- 20181.03B-1.7%
- 20171.05B-4.4%
- 20161.10B-0.4%
- 20151.11B-0.5%
- 20141.11B-0.6%
- 20131.12B-2.6%
- 20121.15B+2.9%
- 20111.11B+0.7%
- 20101.11B+0.7%
- 20091.10B+0.4%
- 20081.09B+0.3%
- 20071.09B+0.4%
- 20061.09B-0.6%
- 20051.09B+0.3%
- 20041.09B+0.9%
- 20031.08B-0.2%
- 20021.08B-0.6%
- 20011.09B-0.5%
- 20001.10B-0.9%
- 19991.11B-1.3%
- 19981.12B-0.9%
- 19971.13B+1.2%
- 19961.12B-5.1%
- 19951.18B+0.8%
- 19941.17B-2.7%
- 19931.20B+3.3%
- 19921.16B-0.1%
- 19911.16B+1.1%
- 19901.15B-2.0%
- 19891.17B+3.4%
- 19881.14B-1.2%
- 19871.15B+5.0%
- 19861.09B-0.6%
- 19851.10B—
Shares Outstanding values are taken from Eli Lilly's reported income statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About Shares Outstanding at Eli Lilly (LLY)
According to Eli Lilly's latest reported financial statements, the company's latest reported diluted shares outstanding is 895.90M. Diluted weighted-average shares outstanding is the share count used to compute per-share metrics like EPS. Buybacks lower it; new issuance, stock-based compensation, and convertible securities raise it. Multiply by the stock price for market capitalization.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
2025's annual diluted shares outstanding for Eli Lilly (LLY) came in at 898.00M – edged down 0.7% year-over-year.
Over 2020–2025 (5 years), Eli Lilly diluted shares outstanding expanded at a -1.3% compound annual rate, with a net decline across the window.
Eli Lilly diluted shares outstanding peaked at 1.20B in 1993; the latest annual figure is 898.00M in 2025 (25.2% below peak).
The record annual diluted shares outstanding stands at 1.20B, reached in 1993; the historical low of 898.00M was recorded in 2025.
Eli Lilly Shares Outstanding by Year
Eli Lilly Shares Outstanding 2025: 898.00M
Eli Lilly diluted shares outstanding in 2025 was 898.00M, edged down 0.7% below 2024. This figure represents the lowest annual value in the available history.
Eli Lilly Shares Outstanding 2024: 904.06M
2024's diluted shares outstanding for Eli Lilly came in at 904.06M, edged up 0.1% from 2023.
Eli Lilly Shares Outstanding 2023: 903.28M
Eli Lilly posted diluted shares outstanding of 903.28M in 2023, edged down 4.9% below 2022.
Eli Lilly Shares Outstanding 2022: 950.18M
In 2022, Eli Lilly reported diluted shares outstanding of 950.18M, edged down 0.4% below 2021.
Eli Lilly Shares Outstanding 2021: 953.65M
Eli Lilly diluted shares outstanding in 2021 was 953.65M.
See more financial history for Eli Lilly (LLY).
Sector peers by Shares Outstanding
Healthcare peers of Eli Lilly (LLY), ranked by their latest diluted shares outstanding
| 4.45B | |
| 2.51B | |
| 2.43B | |
| 1.77B | |
| 1.56B | |
| 910.00M | |
| 542.00M | |
| 377.00M |
- 4.45B
- 2.51B
- 1.77B
- 1.56B
- 910.00M
- 542.00M
Frequently asked questions
Eli Lilly (LLY) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation